Oliver Tomkins

Haematology ST7 | PhD @Cambridge_Uni @SCICambridge. High-grade B-cell genomics and modelling.

[NEJM @NEJM]

Original Article: Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia https://t.co/bWmV87Yf2a

#ASH25 | @ASH_hematology

[NICE @NICEComms]

NICE has published final draft guidance recommending glofitamab with gemcitabine and oxaliplatin as an option for some people with relapsed or refractory diffuse B-cell lymphoma.

Read the draft guidance: https://t.co/XC68Taw9fB

[Oliver Tomkins @TomkinsOliver]

Bing-Neel Syndrome - A Case Series of 46 Patients from the United Kingdom https://t.co/h7rYm8kPGi

[Graham Collins @graham74GC]

Great news - NICE have approved AVD-BV for 1L treatment of advanced stage Hodgkin Lymphoma. Great to have an additional option for these patients. #lymsm

https://t.co/SIWWshjzw4

[Chris Fox @ProfChrisPFox]

STARGLO Ph3 RCT - substantial OS benefit with glofitamab-GemOx for pts w rrLBCL unsuitable for ASCT. A new standard of care in this area of unmet need. A landmark trial. https://t.co/zI1iNbcGcU

[Bread & Butter Haematology @MorphologyAmigo]

A bit of High Grade Lymphoma Genomics to start your Monday Morning👇👇

The More you dig deeper - The More Interesting the Landscape Gets 😜

How deep does the rabbit hole go to Wonderland 🤔🤔
https://t.co/EFzMAKj6ab
#hematology #lymsm #hemepath #medtwitter

[Georgia McCaughan @gjmccaughan]

Upfront treatment of POEMS from UCLH Registry by Oliver Tomkins #IMS24
142 pts, 104 with systemic disease

59 had ASCT, 30/59 had induction
Haem ORR 83%.
5 year OS 96%
No difference in CR rate, PFS or OS if induction used or not

36 not ASCT eligible
ORR 52.7%
5 year OS 68.4%

[Neil Stone @DrNeilStone]

Look at that beautiful ZERO..no HIV transmissions in over 2000 women who had a twice yearly injection of Lenacapavir.

Is this is how we are finally going to end the HIV pandemic?

Here's the full paper

https://t.co/NWWt0djpaA

[David Steensma, MD @DavidSteensma]

Did you ever wonder why our marrow is located inside of our *bones*, #MedTwitter? There’s no a priori anatomical reason it should be sited there. Blood cells could form in our spleens & livers, as they do during our fetal lives; or elsewhere, as in some animals. Let’s discuss! /1

[Oliver Tomkins @TomkinsOliver]

@TK_HelpDesk Thanks. See reply

[Oliver Tomkins @TomkinsOliver]

@TK_HelpDesk Hello. I need urgent help with a booking. Please confirm you’ve seen DM

[Tanya Skrypets @TSkrypets]

Additionally, Also my colleagues from national Cancer Institute (Kiev) did auto SCT for lymphoma patient in a bombshell!!! You cannot plan transplant based on a bombing timetable😡 @TheEBMT @EHA_Hematology @ASH_hematology @StefanoLuminari @AnnaSureda5 @Mohty_EBMT

[Oliver Tomkins @TomkinsOliver]

@medichulston And onto haem?

[Oliver Tomkins @TomkinsOliver]

Beautiful morning for the Paris marathon

[Oliver Tomkins @TomkinsOliver]

@medichulston Six a night? Slacking

[Blood Journals Portfolio @BloodPortfolio]

Real-world experience with caplacizumab in the management of acute TTP https://t.co/VoFLvTQLy4 #TTP

[Oliver Tomkins @TomkinsOliver]

Real-World Evidence of Caplacizumab Use in the Management of Acute TTP | Blood | American Society of Hematology https://t.co/LYYaC7UmAO

[Oliver Tomkins @TomkinsOliver]

@DrHelenOram @charltonbakehse Amazing! Friday treat?

[The Lancet Haematology @TheLancetHaem]

Our joint Series with @TheLancetHIV on HIV-related haematological malignancies is live now! Visit the Series Hub to learn more on how work on haematological cancers, a defining feature of HIV, is providing insights into how a cure for HIV might be achieved https://t.co/qCvgHODYxg

[Oliver Tomkins @TomkinsOliver]

@medichulston Best hospital in London!